Many people are able to conceive and have healthy pregnancies after age35. However, fertility gradually changes with age, and reproductive timing becomes increasingly important when pregnancy is a current or future goal.
Age 35 should not be understood as a sudden cutoff where fertility dramatically changes overnight. Rather, fertility declines progressively over time, with age becoming an increasingly important factor in both natural conception and fertility treatment. The American Society for Reproductive Medicine (ASRM) identifies female age as the single most important predictor of fecundity and recommends earlier fertility evaluation beginning at age 35 because delays may become more significant as reproductive age advances (ASRM, 2021).
Age-related fertility changes involve more than one factor. They may include changes in:
At the same time, fertility is never determined by age alone. Ovulation, fallopian-tube health, uterine conditions, sperm health, medical history, and other reproductive factors are also important.
Understanding these different pieces can help patients make informed decisions without viewing age 35 as an absolute fertility deadline.
Egg Quantity
Women are born with a finite number of oocytes, or eggs. The number of remaining eggs gradually decreases throughout reproductive life.
This remaining pool is referred to as ovarian reserve.
AMH and antral follicle count (AFC) are commonly used to estimate ovarian reserve. Both tend to decline as reproductive age increases, although ovarian reserve can vary considerably between people of the same age (ASRM,2020).
This means that a 38-year-old patient and another 38-year-old patient may have very different ovarian reserve results.
Egg Quality
Egg quantity and egg quality are not the same thing.
Ovarian reserve testing primarily provides information about the number of eggs or follicles that may remain. It does not directly measure the quality of those eggs (ASRM, 2020).
Egg quality is closely related to the ability of an egg to fertilize, develop into an embryo, and ultimately contribute to a healthy pregnancy.
As maternal age increases, chromosomal abnormalities in eggs and embryos become more common. This is one important reason why fertility rates decline and pregnancy-loss risk increases with reproductive aging. ASRM recognizes advanced maternal age as a risk factor for infertility and pregnancy loss, and current reproductive-medicine guidance also recognizes increasing embryo aneuploidy with maternal age (ASRM, 2024; ASRM, 2025).
Time to Pregnancy
The probability of conception within an individual menstrual cycle generally declines as reproductive age advances.
This does not mean that natural pregnancy cannot occur after 35. Rather, it means that it may take longer to conceive, and there may be less time available to identify and address an underlying fertility issue.
For this reason, fertility evaluation is generally recommended sooner for patients age 35 and older than for younger patients (ASRM, 2021).
Pregnancy-Loss Risk
Pregnancy loss can occur at any reproductive age and has many possible causes.
However, age-related changes in egg and embryo chromosomal health contribute to an increasing risk of miscarriage as maternal age advances. ASRM identifies advanced maternal age as a risk factor for pregnancy loss (ASRM, 2025).
Age is only one factor, however. Uterine conditions, genetic factors, endocrine conditions, medical conditions, and other reproductive factors may also contribute to pregnancy loss.
Age-related fertility decline does not usually produce a specific symptom.
A patient can have regular menstrual cycles and still experience changes in ovarian reserve or egg quality.
Common reasons patients seek fertility evaluation after age 35 include:
A regular period does not provide a complete measure of ovarian reserve or overall fertility.
Likewise, a low AMH result does not mean that natural pregnancy is impossible.
Natural Decline in Ovarian Reserve
The number of remaining oocytes gradually declines throughout reproductive life. AMH and AFC commonly decline as this follicular pool becomes smaller (ASRM, 2020).
Age-Related Changes in Egg Quality
Increasing reproductive age is associated with a greater likelihood of chromosomal abnormalities in eggs and embryos. This can affect embryo development, implantation, and pregnancy loss.
Changes in Ovarian Response
Patients with lower ovarian reserve may sometimes develop fewer follicles in response to ovarian-stimulation medications.
Endometriosis
Endometriosis may affect fertility through multiple mechanisms and may become an additional consideration when reproductive time is increasingly important.
Fibroids or Other Uterine Conditions
Certain fibroids, polyps, adhesions, or uterine abnormalities may affect fertility depending on their location and severity.
Previous Ovarian Surgery
Surgery involving the ovaries can sometimes affect ovarian reserve, depending on the underlying condition and the extent of ovarian tissue involved.
Male Fertility Factors
Fertility evaluation should not focus only on female age.
ASRM recommends evaluating the male partner in parallel when applicable because sperm-related factors may contribute to difficulty conceiving (ASRM,2021).
A semen analysis may therefore be an important part of the fertility evaluation even when the female partner is over age 35.
There is no single test that can measure a person’s overall fertility.
A fertility evaluation may include several pieces of information.
Menstrual and Reproductive History
A fertility specialist may review:
Ovarian Reserve Testing
Testing may include:
AMH and AFC are currently among the most useful markers of ovarian reserve and can help predict how the ovaries may respond to stimulation during IVF (ASRM, 2020).
However, ovarian reserve testing should not be interpreted as a direct fertility test.
Fallopian-Tube Evaluation
Tests such as hysterosalpingography (HSG) or sonohysterography may be used when appropriate to determine whether the fallopian tubes are open and to evaluate reproductive anatomy (ASRM, 2021).
Uterine Evaluation
Ultrasound or other imaging may be used to evaluate conditions such as:
Semen Analysis
A semen analysis may evaluate:
Male evaluation should ideally occur alongside female fertility evaluation when applicable rather than waiting until female testing has been completed (ASRM, 2021).
Treatment after age 35 depends on much more than age alone.
The fertility specialist may consider:
Timed Intercourse
When ovulation is occurring and no major fertility factor is identified, patients may continue attempting natural conception with appropriately timed intercourse.
Ovulation Induction
Medications such as letrozole or clomiphene citrate may be used when ovulation needs medical support or when controlled follicular development is part of the treatment plan.
Intrauterine Insemination (IUI)
IUI may be considered when the fallopian tubes, ovarian response, semen parameters, and other fertility factors make this approach appropriate.
In Vitro Fertilization (IVF)
IVF may be considered when:
Preimplantation Genetic Testing for Aneuploidy (PGT-A)
PGT-A is a laboratory technique that evaluates embryos created through IVF for chromosomal abnormalities before transfer.
Because embryo aneuploidy becomes more common with advancing maternal age, PGT-A may be discussed with some patients undergoing IVF.
Egg or Embryo Freezing
Patients who are not ready to become pregnant but are concerned about future reproductive timing may discuss oocyte or embryo cryopreservation with a fertility specialist.
The decision should consider age, reproductive goals, expected ovarian response, and individual circumstances rather than relying on AMH alone.
Acupuncture cannot reverse reproductive aging, increase the number of eggs remaining in the ovaries, or guarantee improved egg quality.
Instead, fertility acupuncture may be used as complementary care to support aspects of reproductive physiology, overall health, and treatment-related well-being.
Supporting Ovarian and Pelvic Circulation
Acupuncture may influence autonomic nervous-system activity and local vascular regulation and has been studied for possible effects on reproductive blood flow.
For patients preparing for natural conception, IUI, or IVF, acupuncture may be incorporated as supportive care aimed at maintaining a healthy pelvic and ovarian environment.
Supporting the Environment for Follicular Development
Acupuncture cannot create additional follicles or reverse age-related changes. A more appropriate goal is to support ovarian circulation, nervous-system regulation, sleep, stress management, and the physiological environment in which follicles develop.
Because follicle development occurs over an extended period, fertility acupuncture is often started in advance of an IVF or IUI cycle rather than only immediately before a procedure.
Supporting Uterine Blood Flow and the Endometrial Environment
The endometrium is the tissue that develops inside the uterus and provides the environment in which embryo implantation occurs.
Acupuncture may be incorporated into fertility care with the goal of supporting uterine circulation and the overall endometrial environment before embryo transfer.
Supporting IUI or IVF Treatment
For patients using assisted reproductive treatment, acupuncture may be adjusted according to the treatment stage.
This may include supportive care:
Treatment is intended to complement—not replace—the medications, procedures, monitoring, and recommendations provided by the fertility clinic.
There is no single fertility acupuncture protocol for every patient over age 35.
Treatment may be individualized according to age, menstrual cycle, ovarian reserve, fertility diagnosis, treatment history, symptoms, and whether the patient is trying naturally or undergoing IUI or IVF.
Trying to Conceive Naturally
When trying naturally, treatment may be coordinated with the menstrual cycle.
The approach may focus on:
Preparing for IUI
Support may focus on:
Preparing for IVF
Before IVF, treatment may be coordinated with the anticipated stimulation and retrieval schedule.
Acupuncture may be used as complementary support for:
Before and After Egg Retrieval
As follicles enlarge during ovarian stimulation, patients may experience pelvic pressure, bloating, fatigue, or discomfort.
Treatment before retrieval may be modified to support pelvic circulation and physical comfort.
After retrieval, gentle acupuncture may be used to support recovery from mild symptoms such as cramping, bloating, digestive changes, fatigue, or muscular tension.
Severe pain, significant abdominal swelling, shortness of breath, heavy bleeding, persistent vomiting, dizziness, or other concerning symptoms require prompt communication with the fertility clinic.
Before Embryo Transfer
When a fresh or frozen embryo transfer is planned, treatment may shift toward:
Between Fertility Treatment Cycles
Not every patient proceeds immediately from one treatment cycle to another.
During a break between cycles, acupuncture may be used to support:
Age influences how long patients are generally advised to try before seeking evaluation.
According to ASRM:
Evaluation should not necessarily be delayed for six months when a known fertility concern is already present.
Earlier evaluation may be appropriate when there is:
ASRM specifically recommends prompt evaluation when a known medical history or condition is associated with infertility (ASRM, 2021).
Seeking an evaluation does not necessarily mean that IVF is required. The purpose is to understand the fertility picture earlier so that patients can make informed decisions about timing and available options.
Disclaimer
This website and its contents are intended for informational purposes only and are not intended to diagnose, treat, cure, or prevent any disease. Whenever possible, patients are advised to seek professional care from a qualified healthcare professional for proper medical evaluation and treatment.
References